Basic Information
Company Description
Past Progress
Risk
Why is it a good investment?
100

What is Fulgent's Ticker Symbol?

FLGT

100

What sector is Fulgent in?

Healthcare

100

What has caused Fulgent's recent growth?

Covid-19 Testing.

How can that be a problem?

100

What is Fulgent highly reliant on?

Its customers

100

How has the average selling price of tests changed?

The average selling price cut in half from $1,200 down to $589 over the same time frame (Q1 2017 to Q1 2020).

200

Where is Fulgent Located?

Temple City, California

200

Who is Fulgent's CEO?

Ming Hsieh

200

What does Fulgent's ability to scale allow it to do? What does that mean?

It allows it to increase its profits substantially faster than its revenue.

Most of the company's revenue(money made) is turning into profit(money made - expenses), so they have more money to spend.

200

What company provides Fulgent with genetic sequencing machines that they use to run their tests?

Illumina (Ilmn)

200
What is the change in price for Fulgent to produce tests?

In the first quarter of 2017, it cost Fulgent $420 to run its tests. Three years later, in the first quarter of 2020, that figure had fallen to $308.

300

What is Fulgent's Current 52wk high and low?

High: $66

Low:  $6.70

300

What does Fulgent provide for its customers?

Fulgent is a healthcare company providing genetic testing for single-gene mutations, rare diseases, and whole-genome sequencing.

300

Which institutions have given Fulgent contracts to test for Covid-19? (Name all of them)

Large cities for drive through testing, Fortune 100 companies, and a major NCAA conference

300

In the short term, Fulgent is dependent on the COVID-19 pandemic continuing. How can that impact its growth?

If Covid-19 were to end, it would lose a lot of sales. Causing its Stock Price to take a massive hit. 

300

How has Fulgent's product offering improved?

Fulgent has constantly improved its product offerings and now sells tests to examine more than 18,000 single genes and more than 800 rare diseases.

400

What is Fulgent's, Mkt Cap? What does this tell us about the company?

1.1 - 1.6 billion - (How much the company is valued at)

This tells us that this company is a small cap company (under $2 billion). This means this is a relatively small company. 

400

What kind of testing has Fulgent recently started doing?

Covid-19 Testing

400

How much did Fulgent's revenue and earnings per share (eps) increase last quarter?

Revenue: 880%

EPS: 2,375% ($0.08 to $1.98)

400

What are the positives if Covid-19 were to end?

The company would focus on genetics testing (original purpose), and they would have secured a lot of insurance contracts.

400

How much did test volume and revenue increase?

Test volume soaring almost 5,000% year over year and revenue rising nearly 900% in the third quarter of 2020.

500

Does Fulgent offer dividends? If no or yes, what does that tell us about the company?

It does not give dividends. 

This tells us that they're focused on growing, so all the money made is reinvested in the company. 

This stock will not make us money until we sell it.

500

What is Fulgent at its core?

Fulgent is a technology platform company.

What does that mean?

500
What is Fintech? Why do they think Fulgent will be a leader in Fintech if they're a healthcare company?

Fintech (Financial Technology)

They're a healthcare company but they're using methods similar to fintech companies, to scale and increase their stock price.

500
What percent of its revenue is contributed by 3 of the company's clients?

One of the company’s clients contributed 37% of its revenue in the third quarter; two other customers added 29% and 26% of total accounts receivable

500

Why is Ming Hsieh being the CEO a good thing?

As a result, Hsieh owns about 34% of Fulgent, giving him plenty of incentive to grow the company — and the share price along with it.

Since he owns so much of the company, if it fails he loses a lot of money.

M
e
n
u